UNITED STATES
                    SECURITIES AND EXCHANGE COMMISSION
                          Washington, D.C. 20549


                                 FORM 8-K

                              CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) August 12, 2004

                  CareDecision Corporation. (OTCBB: CDED)
            (Exact name of Registrant as specified in charter)


             Nevada              000-33187           91-2105842
 (State or other jurisdiction   (Commission       (I.R.S. Employer
       of incorporation)        File Number)       Identification)


 2660 Townsgate Road, Suite 300, Westlake Village, CA         91361
      (Address of principal executive offices)              (Zip Code)


 Registrant's telephone number, including area code:    (805) 446-1973


/1/


ITEM 8.01 OTHER EVENTS

CareDecision  Corporation ("CareDecision" or the  "Company")
[OTCBB:  CDED] announced August 12, 2004 that our  Board  of
Directors received a proposal for a possible merger  with  a
division  or  divisions of a company with  several  business
interests  that are similar to ours.  Our Board of Directors
met  Friday,  August  13, 2004 to consider  this  and  other
opportunities, some previously disclosed, with the objective
of enhancing shareholder value.

As  our business focuses on the development of solutions for
wireless  handheld  devices, we have,  from  time  to  time,
received inquiries from other companies who desire to either
enter  this segment of the technologies industry, or bolster
their existing competitive position.  Our Board of Directors
has  a responsibility to consider all offers and to base its
decisions   on  what  is  in  the  best  interest   of   our
shareholders.

On August 18, 2004, we announced that our Board of Directors
had  reviewed the above referenced merger offer, and  agreed
unanimously to prepare two counteroffers with the  hopes  of
moving   the   negotiations  forward  toward  an  agreement.
Although the merger, as proposed, would increase our  market
capitalization and provide for additional revenue  producing
opportunities,   our  Board  of  Directors  prepared   these
counteroffers  with  the  belief  that  the  technology  and
capabilities  CareDecision  possesses  exceed  this  initial
offer.   The  Board of Directors plans to provide additional
updates  as  circumstances  warrant  and  believes  that   a
satisfactory conclusion can be reached.

On  August  25,  2004, our Board of Directors  announced  an
agreement to merge with Kelly Companies forming NEXT GENeSYS
Corp,  with terms based on the recent CareDecision  counter-
proposal,  and  subject only to usual and customary  closing
activities.  The union will create a new public company with
an  increased  projected  market  capitalization  (based  on
expected post merger prices).

In  addition  to  growing the combined  companies'  existing
wholesale  prescription drug and e-lodging businesses,  NEXT
GENeSYS  Corp. will initially target the 40 million minority
Americans  without any presently available healthcare  focus
through a direct campaign, in line with stated goals of both
State and Federal administrations, which offers prescription
support  via  clinics,  physicians  networks,  and  wellness
checks.

"This  merger is the final element in a series of  strategic
activities initiated over two years ago.  In anticipation of
such   a   conclusion,  we  have  conducted  meetings   with
government  officials, major pharmaceutical  companies,  and
healthcare  organizations  encompassing  more  than   25,000
physicians.     We    have   also   developed    significant
infrastructure  related to our mail-order  pharmacy  through
wireless technologies", commented Ronald Kelly, the incoming
Chairman  and Chief Executive Officer of NEXT GENeSYS  Corp.
"We  have basic agreements with multiple minority and  other
client organizations, providing confidence in our ability to
achieve  a significant presence in this market.  Our ability
to couple wireless connectivity solutions for doctors with a
state-of-the-art e-pharmacy for direct drug distribution has
the   capability  to  revolutionize  the  way  we   targeted
Americans receive medications.


/2/


The Convergence of companies couples CareDecision's patents-
pending WiFi handheld technology ad installed WiFi hotel  e-
business  networks, with the wireless PC  and  PDA  hardware
distribution,  wholesale  and mail  order  retail  drug  and
medical   supply   distribution,  physician   to-fulfillment
networks,  and  other wireless technology solutions  brought
into  the  new company by the Kelly Companies.   The  merger
will  thus  create  a  unique  wireless-centered  e-business
enterprise  strategically positioned to capture  significant
market share by delivering affordable healthcare and related
technology  products  and  service  to  both  consumer   and
business.

Mr. Kelly concluded, "Modernizing the healthcare system is a
priority for both Presidential candidates, and building upon
our  existing  base  of business through  this  merger  will
create a significant business force in accomplishing a major
delivery system improvement for American minority, uninsured
and   under-insured   population.   Our   unique   solution,
combining   the   in-house   technologies   and   technology
creations,   coupled  with  our  capability  to   distribute
prescription  drugs to America's poor and  under-insured  at
what   will   be  perceived  as  discounted  prices,   could
eventually  allow us to transfer our unique  business  model
and  automate  the process of prescribing  medicine  to  all
Americans."



Date: August 31, 2004.
      ---------------


CareDecision Corporation


/s/ Keith Berman
- -----------------
Keith Berman, CFO


/3/